InsiderClue
← All stocks

GYRE THERAPEUTICS, INC.

GYRE Net selling
CIK 0001124105 #2796 in the set updated 21 Sep 2026
Bought (120 mo)
$123.10K
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$6.11M
$1.63M on a plan · $1.86M straight out of an exercise
Sold at will
$2.61M
6 of 116 sales
Net
−$5.99M
−$2.49M against sales at will

By person

21 insiders · 151 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Flynn James E
10% owner
—
$2.19M (5)
−$2.19M
1,113,222
0.9983%
$7.07M
−6.1%
Ma Songjiang
President
—
$1.55M (85) scheduled
−$1.55M
2,806,084
2.52%
$17.82M
−4.6%
USMAN NASSIM
Director
$27.41K (6)
$992.21K (6) scheduled
−$964.81K
11,260
0.0101%
$71.50K
—
Ye Weiguo
Chief Operating Officer
—
$869.95K (16) scheduled
−$869.95K
700,000
0.6277%
$4.45M
—
LAWLOR AUGUSTINE
Director
—
$423.51K (1)
−$423.51K
118,189
0.1060%
$750.50K
−14.9%
Luo Ying
Chief Executive Officer
—
$82.93K (2) scheduled
−$82.93K
2,565,226
2.30%
$16.29M
—
Levy Howard
Chief Medical Officer
$28.98K (4)
$1.90K (1) scheduled
+$27.08K
40,123
0.0360%
$254.78K
+24.7%
Ling Geoffrey M.D.
Director
$18.69K (1)
—
+$18.69K
31,790
0.0285%
$201.87K
—
Richard John P
Director
$17.98K (2)
—
+$17.98K
3,716
0.0033%
$23.60K
+1,620%
Williams Eddie
Director
$11.56K (1)
—
+$11.56K
34,804
0.0312%
$221.01K
+27,091%
Cai Veronica
Controller
$8.22K (1)
—
+$8.22K
7,353
0.0066%
$46.69K
+100.1%
Blouse Grant E.
Chief Scientific Officer
$7.23K (3)
—
+$7.23K
9,417
0.0084%
$59.80K
+436.9%
Miller Seline E.
SVP Finance; Interim CFO & PAO
$3.02K (2)
—
+$3.02K
6,500
0.0058%
$41.28K
+99,900%
GNI Group Ltd. entity
10% owner
—
—
—
64,005,887
57.40%
$406.44M
+14,994%
DESOUZA ERROL B
Director
—
—
—
29,801
0.0267%
$189.24K
+12,266%
Hunt Andrea
Director
—
—
—
28,228
0.0253%
$179.25K
+99,900%
Eastling Thomas Wilson
Chief Financial Officer
—
—
—
15,000
0.0135%
$95.25K
—
Payne Fletcher
Chief Financial Officer
—
—
—
4,911
0.0044%
$31.18K
+320.8%
TETLOW SHARON
Director
—
—
—
3,635
0.0033%
$23.08K
—
HILL STEPHEN A
Director
—
—
—
1,190
0.0011%
$7.56K
−13.8%
GNI Hong Kong Ltd entity
10% owner
—
—
—
0
0.0000%
$0.00
−100.0%

Individual transactions

23
Insider
Date
Role
Action
Shares
Price
Amount
Ye Weiguo
18 Jun 2026
Chief Operating Officer
Sold after exercise
3,000
$6.35
$19.05K
Ye Weiguo
11 Jun 2026
Chief Operating Officer
Sold after exercise
2,800
$6.17
$17.28K
Ye Weiguo
10 Jun 2026
Chief Operating Officer
Sold after exercise
6,418
$6.21
$39.86K
Ye Weiguo
10 Jun 2026
Chief Operating Officer
Sold after exercise
5,000
$6.24
$31.20K
Ye Weiguo
9 Jun 2026
Chief Operating Officer
Sold after exercise
14,500
$6.14
$89.03K
Ye Weiguo
9 Jun 2026
Chief Operating Officer
Sold after exercise
3,000
$6.15
$18.45K
Ye Weiguo
5 Jun 2026
Chief Operating Officer
Sold after exercise
15,401
$6.40
$98.57K
Ye Weiguo
4 Jun 2026
Chief Operating Officer
Sold after exercise
19,575
$6.13
$119.99K
Ye Weiguo
26 May 2026
Chief Operating Officer
Sold after exercise
4,000
$6.10
$24.40K
Ye Weiguo
22 May 2026
Chief Operating Officer
Sold after exercise
3,500
$6.08
$21.28K
Ye Weiguo
21 May 2026
Chief Operating Officer
Sold after exercise
12,820
$6.15
$78.84K
Ye Weiguo
20 May 2026
Chief Operating Officer
Sold after exercise
9,400
$6.15
$57.81K
Ye Weiguo
19 May 2026
Chief Operating Officer
Sold after exercise
9,120
$6.37
$58.09K
Ye Weiguo
18 May 2026
Chief Operating Officer
Sold after exercise
200
$6.62
$1.32K
Ye Weiguo
15 May 2026
Chief Operating Officer
Sold after exercise
13,100
$6.65
$87.12K
Ye Weiguo
14 May 2026
Chief Operating Officer
Sold after exercise
15,580
$6.91
$107.66K
USMAN NASSIM
28 Jun 2024
Director
Sold after exercise
3,452
$12.00
$41.44K
USMAN NASSIM
1 May 2024
Director
Sold after exercise
100
$15.63
$1.56K
USMAN NASSIM
1 May 2024
Director
Sold after exercise
5,000
$14.90
$74.50K
USMAN NASSIM
1 May 2024
Director
Sold after exercise
14,900
$13.86
$206.51K
USMAN NASSIM
1 Apr 2024
Director
Sold after exercise
20,000
$16.15
$323.00K
USMAN NASSIM
15 Mar 2024
Director
Sold after exercise
20,000
$17.26
$345.20K
Levy Howard
16 Nov 2018
Chief Medical Officer
Sold after exercise
173
$11.00
$1.90K
Show all 151 transactions →

What was left out

Form 4 filings counted 269
Amendments (4/A) skipped 6
Filings about a different issuer 0
Unreadable filings 0
Joint filings 5
Sales on a Rule 10b5-1 plan 87
Sales straight out of an exercise 23
Sales at will 6
Transactions with no price 0
Shares from compensation/vesting 72,958,443
Sales filed before the plan box existed 6
History held since 12 Jul 2017